Cholesterol, apolipoproteins, and the risk of myocardial infarction

David Crook; Ian F. Godsland; Victor Wynn; Robert S. Rosenson; Robert I. Myers; Joel A. Simon; Warren S. Browner; Stephen B. Hulley; Meir J. Stampfer; Frank M. Sacks; Simonetta Salvini; Walter C. Willett; Charles H. Hennekens

doi:10.1056/NEJM199202133260715

Cholesterol, apolipoproteins, and the risk of myocardial infarction

David Crook, Ian F. Godsland, Victor Wynn, Robert S. Rosenson, Robert I. Myers, Joel A. Simon, Warren S. Browner, Stephen B. Hulley, Meir J. Stampfer, Frank M. Sacks, Simonetta Salvini, Walter C. Willett, Charles H. Hennekens

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: Although the status of plasma high-density lipoprotein (HDL) levels as a marker of protection against cardiovascular disease is well established, the value of more detailed analyses of this class of lipoproteins is less certain. Stampfer et al. (Aug. 8 issue)¹ evaluated the predictive strength of HDL subfractions in 246 men who had myocardial infarction and 246 controls. The authors concluded that measurement of the HDL subfractions (HDL₂ and HDL₃) was no more predictive than measurement of total HDL. This finding contrasts with those of case–control studies in which HDL₂ appeared to be a. . .

Original language	English
Pages (from-to)	490-492
Number of pages	3
Journal	New England Journal of Medicine
Volume	326
Issue number	7
DOIs	https://doi.org/10.1056/NEJM199202133260715
State	Published - 13 Feb 1992
Externally published	Yes

Access to Document

10.1056/NEJM199202133260715

Cite this

@article{b6f7936fb7f04e09b2739253ac1dbee7,

title = "Cholesterol, apolipoproteins, and the risk of myocardial infarction",

abstract = " To the Editor: Although the status of plasma high-density lipoprotein (HDL) levels as a marker of protection against cardiovascular disease is well established, the value of more detailed analyses of this class of lipoproteins is less certain. Stampfer et al. (Aug. 8 issue)1 evaluated the predictive strength of HDL subfractions in 246 men who had myocardial infarction and 246 controls. The authors concluded that measurement of the HDL subfractions (HDL2 and HDL3) was no more predictive than measurement of total HDL. This finding contrasts with those of case–control studies in which HDL2 appeared to be a. . .",

author = "David Crook and Godsland, {Ian F.} and Victor Wynn and Rosenson, {Robert S.} and Myers, {Robert I.} and Simon, {Joel A.} and Browner, {Warren S.} and Hulley, {Stephen B.} and Stampfer, {Meir J.} and Sacks, {Frank M.} and Simonetta Salvini and Willett, {Walter C.} and Hennekens, {Charles H.}",

year = "1992",

month = feb,

day = "13",

doi = "10.1056/NEJM199202133260715",

language = "English",

volume = "326",

pages = "490--492",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Cholesterol, apolipoproteins, and the risk of myocardial infarction

AU - Crook, David

AU - Godsland, Ian F.

AU - Wynn, Victor

AU - Rosenson, Robert S.

AU - Myers, Robert I.

AU - Simon, Joel A.

AU - Browner, Warren S.

AU - Hulley, Stephen B.

AU - Stampfer, Meir J.

AU - Sacks, Frank M.

AU - Salvini, Simonetta

AU - Willett, Walter C.

AU - Hennekens, Charles H.

PY - 1992/2/13

Y1 - 1992/2/13

N2 - To the Editor: Although the status of plasma high-density lipoprotein (HDL) levels as a marker of protection against cardiovascular disease is well established, the value of more detailed analyses of this class of lipoproteins is less certain. Stampfer et al. (Aug. 8 issue)1 evaluated the predictive strength of HDL subfractions in 246 men who had myocardial infarction and 246 controls. The authors concluded that measurement of the HDL subfractions (HDL2 and HDL3) was no more predictive than measurement of total HDL. This finding contrasts with those of case–control studies in which HDL2 appeared to be a. . .

AB - To the Editor: Although the status of plasma high-density lipoprotein (HDL) levels as a marker of protection against cardiovascular disease is well established, the value of more detailed analyses of this class of lipoproteins is less certain. Stampfer et al. (Aug. 8 issue)1 evaluated the predictive strength of HDL subfractions in 246 men who had myocardial infarction and 246 controls. The authors concluded that measurement of the HDL subfractions (HDL2 and HDL3) was no more predictive than measurement of total HDL. This finding contrasts with those of case–control studies in which HDL2 appeared to be a. . .

UR - http://www.scopus.com/inward/record.url?scp=0026604978&partnerID=8YFLogxK

U2 - 10.1056/NEJM199202133260715

DO - 10.1056/NEJM199202133260715

M3 - Letter

C2 - 1732782

AN - SCOPUS:0026604978

SN - 0028-4793

VL - 326

SP - 490

EP - 492

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Cholesterol, apolipoproteins, and the risk of myocardial infarction

Abstract

Access to Document

Fingerprint

Cite this